Cover Image for Diagnostics Reimagined: Investing in Healthcare's Next Wave
Cover Image for Diagnostics Reimagined: Investing in Healthcare's Next Wave
Avatar for District Angels
Presented by
District Angels
41 Went

Diagnostics Reimagined: Investing in Healthcare's Next Wave

Zoom
Registration
Past Event
Welcome! To join the event, please register below.
About Event

Join us for an exclusive virtual roundtable exploring how AI-powered diagnostics are transforming healthcare, featuring expert insights and live diligence on CurieDX, a "lab in your pocket" disrupting point-of-care testing.

What to expect:

  • ​🎙️ Expert perspectives from healthcare leaders, advisors, and investors like:

    • Rob Wray: Johns Hopkins Tech Ventures & CurieDX advisor for CurieDX

    • Evan Benkert: Healthcare consultant and operator with a decade of digital healthcare and pharmaceutical expertise

    • Abishek (Abi) Kulshreshtha: Executive Director of the Maryland Innovation Initiative @ TEDCO

  • 💡Live pitch from Therese Canares, founder of CurieDX, MD-based startup delivering faster, remote diagnoses at a fraction of the cost

  • ​🧠 Interactive discussion + Q&A with investors, clinicians, and operators. We will kick off the round table with POVs from:

    • Dr. JD Zipkin: Former Chief Medical Officer of GoHealth and now COO of a NY hospital + CurieDX advisor

  • ​🚀 Early investment opportunity in a high-potential healthtech diagnostics solution

Whether you’re a healthcare insider, a diagnostics and AI nerd, or an angel investor exploring disruptive digital diagnostic opportunities, this is a conversation you won’t want to miss.

-----

💡 Deal Highlight: CurieDX 
Founder: Therese Canares: MD based, former Johns Hopkins pediatric ER doctor, building an AI diagnostics platform for Common Infections because traditional diagnostics tools are slow, expensive, and often inaccurate (64% industry standard)

Raising $1.5M at a $9M pre-money valuation (offering BIITC credit with 50% refund on investment as investor incentive)

​​⚙️ What Makes It Different
CurieDX platform analyzes 64M+ data points to screen common infections (strep, UTI, pink eye) with 90% accuracy from wherever you are

​​👍 Why We're Excited

  • Multi-disease scalable platform (5 patents filed)

  • Early pre-FDA revenue generation with urgent care partners with short sales cycles ​

  • $1.1M+ in non-dilutive funding (BARDA, NSF)

  • Positioned to expand from common to chronic conditions

  • Eligible for Maryland BIITC credit with 50% tax refund availability

Come learn, invest, and back the next wave of DMV innovation.

Want to get involved? You can find the SPV link below- anyone is able to invest: Here

Avatar for District Angels
Presented by
District Angels
41 Went